TROY, N.Y. Julie Stenken, associate professor of analytical chemistry at Rensselaer Polytechnic Institute in Troy, N.Y., has received a four-year, $750,000 grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) to develop a new technique that can be used to study the body's reaction to medical implants at the cellular level. Millions of medical devices, including catheters, pacemakers, vascular grafts, and glucose sensors, are regularly implanted into humans. Despite the frequency of these procedures, implantation still poses a risk of serious side effects, including implant site infection and rejection of the implanted device. The microdialysis technique can provide information that may someday allow doctors to spot infection earlier and prevent rejection from occurring.
Tiny Samples Provide New Understanding
A microdialysis probe (the size of a 0.5 mm pencil lead) is used to withdraw a tiny sample of extracellular fluid at the site where the implant and the body's tissues meet. Analysis of the sample can detect the presence and amount of a variety of chemical markers called cytokines that may indicate early signs of responses to an implant such as infection or rejection. "If you can understand the chemical communication that is going on at the implantation site, you can ultimately bioengineer the site to make it do what is appropriate for the device," says Stenken. "The tools to measure these chemical reactions are just starting to become available to us." Stenken is collaborating with Albany Medical Center co-investigators Daniel Loegering and Michelle Lennartz.
The NIBIB coordinates with the biomedical imaging and bioengineering programs of other agencies and the National Institutes of Health to support imaging and engineering research with potential medical applications.
Stenken's microdialysis project is part of Rensselaer's focal effort to advance biotechnology discoveries for the benefit Page: 1 2 Related biology news :1
Contact: Joely Johnson
Rensselaer Polytechnic Institute
. Berkeley Lab soil scientist Margaret Torn receives Presidential Early Career Award2
. Early detection hope for eye disease3
. Early clinical treatment can halt progression of Alzheimers disease, UCI researchers find4
. Early dexamethasone exposure has long-term neurodevelopment, neuroendocrine effects5
. Early predictor of breast cancer aggressiveness6
. Early treatment confirmed as key to stroke recovery7
. Early identification of kidney disease cost-effective only when directed at high-risk patients8
. Early promise for treatment of Ebola9
. Early treatment can prevent severe vision loss in premature infants10
. Early hominids may have behaved more human than we had thought11
. Early-life environments shape development of stress behaviors and learning abilities in mice